Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Maraviroc in HIV-1 Immunological Non-responders
NCT00884858Phase 4Completed
- Sponsor
- ASST Fatebenefratelli Sacco
- Start
- Apr 2009
- Primary completion
- Apr 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of maraviroc in human immunodeficiency virus infection (HIV) (2 arms), sponsored by ASST Fatebenefratelli Sacco. Primary endpoint: CD4 counts > 200/uL or recovery of CD4 > 25% at 12 months. Started Apr 2009; status: completed.
02
Drugs
maraviroc
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NCT00884858.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00884858.